THELMA Therapeutics Co., Ltd. announced a private placement of common shares for gross proceeds of KRW 4,999,999,900 on December 20, 2021. The transaction will include participation from new investor H-TREPORT for 34.68% stake in the company. The company will receive funding through third party allotment of capital.
THELMA Therapeutics Co., Ltd.
Equities
A015540
KR7015540008
Other Specialty Retailers
1st Jan change | Capi. | |
---|---|---|
+31.83% | 30.48B | |
+6.95% | 5.96B | |
-15.79% | 4.27B | |
+9.87% | 4.01B | |
+4.23% | 1.91B | |
-8.60% | 1.73B | |
-16.18% | 1.23B | |
-17.73% | 1.14B | |
-26.92% | 935M |